Shelter Pharma Limited (BOM:543963)
India · Delayed Price · Currency is INR 37.25
-0.75 (-1.97%)
At close: Sep 25, 2026
Shelter Pharma Revenue
In the fiscal year ending March 31, 2026, Shelter Pharma had annual revenue of 731.34M INR with 44.36% growth. Shelter Pharma had revenue of 398.41M in the half year ending March 31, 2026, with 92.37% growth.
Revenue
731.34M
Revenue Growth
+44.36%
P/S Ratio
0.86
Revenue / Employee
14.34M
Employees
51
Market Cap
627.17M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 731.34M | 224.73M | 44.36% |
| Mar 31, 2025 | 506.60M | 106.37M | 26.58% |
| Mar 31, 2024 | 400.23M | 38.70M | 10.70% |
| Mar 31, 2023 | 361.53M | 60.97M | 20.29% |
| Mar 31, 2022 | 300.56M | 75.72M | 33.68% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Mangalam Drugs & Organics | 2.32B |
| ANG Lifesciences India | 835.87M |
| Source Natural Foods and Herbal Supplements | 796.24M |
| Onyx Biotec | 694.69M |
| Phaarmasia | 486.17M |
| Amwill Health Care | 454.92M |
| Biofil Chemicals and Pharmaceuticals | 346.26M |
| Cian Healthcare | 282.99M |
Shelter Pharma News
- 4 months ago - Shelter Pharma Quarterly report: Q4 2026 - Filings
- 4 months ago - Shelter Pharma Annual report: Q4 2026 - Filings
- 10 months ago - Shelter Pharma Quarterly report: Q2 2026 - Filings